Nu-Med Plus (NUMD) 10-Q 23 Nov 15 2015 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2015	Nov. 20, 2015
Document and Entity Information:
Entity Registrant Name	Nu-Med Plus, Inc.
Document Type	10-Q
Document Period End Date	Sep. 30, 2015
Amendment Flag	false
Entity Central Index Key	1,543,637
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		36,380,444
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Document Fiscal Year Focus	2,015
Document Fiscal Period Focus	Q3
Trading Symbol	numd

Nu-Med Plus, Inc. Balance Sheet

Nu-Med Plus, Inc. Balance Sheets - USD ($)	Sep. 30, 2015	Sep. 30, 2014
Current assets
Cash	$ 211	$ 56,271
Prepaid expenses, current	30,560	115,851
Total current assets	30,771	172,122
Long-term assets
Property and equipment, net	31,950	37,379
Prepaid expenses, long-term	0	3,561
Total long-term assets	31,950	40,940
Total assets	62,721	213,062
Current liabilities
Accounts payable	0	0
Accrued expense	48,626	36,728
Convertible promissory note, due on demand	230,100	230,100
Total current liabilities	278,726	266,828
Stockholders' equity (deficit)
Preferred stock; $0.001 par value per share; 10,000,000 authorized; no shares issued and outstanding, respectively.	0	0
Common stock; $0.001 par value per share; 90,000,000 authorized; 36,131,555 and 34,281,347 shares issued and outstanding, as of September 30, 2015 and December 31, 2014 respectively.	36,132	34,281
Additional paid-in capital	2,326,748	1,703,360
Stock subscription payable	35,750	0
Retained deficit	(2,614,635)	(1,791,407)
Total stockholders' equity (deficit)	(216,005)	(53,766)
Total liabilities and stockholders' equity (deficit)	$ 62,721	$ 213,062

Nu-Med Plus, Inc. Balance Shee3

Nu-Med Plus, Inc. Balance Sheet (Parenthetical) - $ / shares	Sep. 30, 2015	Dec. 31, 2014
Statement of Financial Position
Preferred stock authorized	10,000,000	10,000,000
Preferred stock par value	$ 0.001	$ 0.001
Preferred stock issued	0	0
Preferred stock outstanding	0	0
Common stock authorized	90,000,000	90,000,000
Common stock par value	$ 0.001	$ 0.001
Common stock issued	36,131,555	34,281,347
Common stock outstanding	36,131,555	34,281,347

Nu-Med Plus, Inc. Statements of

Nu-Med Plus, Inc. Statements of Operations - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Income Statement
Revenue	$ 0	$ 0	$ 0	$ 0
Operating expenses
General and administrative expense	8,664	13,541	29,489	49,525
Payroll expense	11,465	13,504	34,910	43,777
Rent expense	3,388	4,164	11,716	12,492
Professional/Consulting Fees	277,997	205,996	729,792	505,236
Depreciation expense	1,855	1,732	5,429	5,196
Total operating expenses	303,368	238,937	811,336	616,226
Operating Loss	(303,368)	(238,937)	(811,336)	(616,226)
Other income/expense
Interest income	0	3	5	5
Interest expense	(4,010)	(4,010)	(11,897)	(42,615)
Total other income/expense	(4,010)	(4,007)	(11,892)	(42,610)
Income tax expense	0	0	0	0
Net loss	$ (307,378)	$ (242,944)	$ (823,228)	$ (658,836)
Basic and diluted loss per share	$ (0.01)	$ (0.01)	$ (0.02)	$ (0.02)
Weighted average common shares outstanding - basic and diluted	35,819,237	32,834,606	35,096,863	32,287,604

Nu-Med Plus, Inc. Statements o5

Nu-Med Plus, Inc. Statements of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Cash flows from operating activities:
Net loss	$ (823,228)	$ (658,836)
Adjustment to reconcile net loss to net cash used in operating activities:
Depreciation	5,429	5,196
Stock for services	532,500	479,480
Services rendered for subscription receivable	3,750	0
Services contributed by officers	409	9,255
Amortization of the Beneficial Conversion Feature	0	30,716
Decrease in prepaid expenses	133,852	0
(decrease) Increase in accounts payable	0	747
Increase in accrued expense	11,899	11,899
Net cash used in operating activities	(135,389)	(121,543)
Cash flows from investing activities:
Net cash used in investing activities	0	0
Cash flows from financing activities
Proceeds from common stock and stock payable	79,329	202,400
Net cash provided by financing activities	79,329	202,400
Net increase/(decrease) in cash	(56,060)	80,857
Cash at beginning of period	56,271	13,229
Cash at end of period	211	94,086
Supplemental schedule of cash flow information
Cash paid for interest	0	0
Cash paid for income taxes	0	0
Supplemental schedule of non-cash financing activities
Common Stock reserved for prepaid services	$ 45,000	$ 0

Organization and Description of

Organization and Description of Business	9 Months Ended
	Sep. 30, 2015
Notes
Organization and Description of Business	NOTE 1 - ORGANIZATION AND DESCRIPTION OF BUSINESS Nu-Med Plus, Inc. is an emerging growth early stage medical device company principally engaged in the design, innovation, development, enhancement and commercialization of beginning, early, and selective later-stage quality medical devices. The Company's immediate focus is on a Nitric Oxide powder formulation that is 99% pure-with one year shelf life, a "desktop" generator device with controls plus safety monitors built in that delivers inhaled Nitric Oxide to replace expensive pressurized canisters and a compact mobile rechargeable device to deliver inhaled Nitric Oxide gas along with research into the application of Nitric Oxide and wound healing. The Company is incorporated in Utah. NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES a. Accounting Method The Company’s financial statements are prepared in accordance with accounting principles generally accepted in the United States of America. In the opinion of management, all adjustments which are necessary for a fair statement of the results for interim periods have been included. b. Revenue Recognition The Company is currently developing its products. It is anticipated that revenue will be recognized on product sales once the product has been shipped to the customers, persuasive evidence of an agreement exists, the price is fixed or determinable, and collectability is reasonably assured. c. Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. d. Cash and Cash Equivalents The Company considers all deposit accounts and investment accounts with an original maturity of 90 days or less to be cash equivalents. e. Fixed Assets Fixed assets are stated at cost. Expenditure for minor repairs, maintenance, and replacement parts which do not increase the useful lives of the assets are charged to expense as incurred. Expenditures, exceeding $500, for new assets or that increase the useful life of existing assets are capitalized. Depreciation is computed using the straight-line method. The lives over which the fixed assets are depreciated are five to seven years. f. Earnings per Share The computation of earnings per share of common stock is based on the weighted average number of shares outstanding during the period of the financial statement as follows: For the Nine Months ended September 30, 2015 For the Nine Months ended September 30, 2014 Net loss (numerator) $ (823,228) $ (658,836) Shares (denominator) 35,096,863 32,287,604 Net loss per share amount $ (0.02) $ (0.02) Diluted earnings per share is computed using the weighted average number of common shares plus dilutive common share equivalents outstanding during the period. During the year there were no outstanding common stock equivalents. Furthermore, due to the net loss for the year, common stock equivalents would not be included in the calculation of the net loss per common share, as their inclusion would be anti-dilutive. g. Income Taxes Deferred taxes are provided on an asset and liability approach whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax basis. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. h. Equity Instruments Issued for Non-Cash Items In accordance with ASC Topic 718, the Company records equity instruments issued for non-cash items at the grant-date fair value of the equity instruments issued. NOTE 3 - GOING CONCERN The Company anticipates that the funds on hand as of September 30, 2015, will not be sufficient and funding through the sale of equity capital and short term related party and other shareholder loans in order to meet the planned expenditures for development, operations, and administrative cost over the next 12 months will be required. Planned expenditures are approximately $300,000 for the next twelve months. The Company is currently funded through November 30, 2015. The Company is in the process of arranging for additional necessary funding and currently retains consultants for that purpose. Management will adjust any salaries and expenditures based on the need for successful continuous operations. If plans to obtain further financing prove to be insufficient to fund operations, continued viability could be at risk. These factors raise substantial doubt about the Company's ability to continue as a going concern.

Fixed Assets

Fixed Assets	9 Months Ended
	Sep. 30, 2015
Notes
Fixed Assets	NOTE 4 - FIXED ASSETS Fixed assets and related accumulated depreciation consisted of the following at September 30, 2015, and December 31, 2014: September 30, 2015 December 31, 2014 Equipment $ 49,373 $ 49,373 Accumulated depreciation (17,423) (11,995) Total Fixed Assets $ 31,950 $ 37,379 Depreciation expense for the nine months ended September 30, 2015 and 2014 was $5,429 and $5,196, respectively.

Preferred and Common Stock

Preferred and Common Stock	9 Months Ended
	Sep. 30, 2015
Notes
Preferred and Common Stock	NOTE 5 - PREFERRED STOCK On October 19, 2011, the Company filed Articles of Incorporation with the State of Utah so as to authorize 10,000,000 shares of preferred stock having a par value of $0.001 per share. No preferred shares are issued or outstanding at September 30, 2014. NOTE 6 - COMMON STOCK In April 2015, the Company entered into a stock subscription agreement with an investor for them to purchase up to $30,000 of common stock at a price of $0.30 per share. In April 2015, the company received $30,000 for the Stock Subscription Payable. The Stock Subscription Payable was relieved on April 2, 2015, by the issuance of 100,000 shares of common stock at a value of $0.30 per share. In April 2015, the Company issued 150,000 common shares valued at $0.30 per share for a total value of $45,000 to a new board member, as compensation, for current and future services to be provided from April 6, 2015, through April 5, 2016. In April 2015, the Company issued 800,000 common shares valued at $0.30 per share for a total value of $240,000 to a new board member, as compensation, for current services. In May 2015, the Company entered into an agreement with a consultant wherein it issued 150,000 common shares valued at $0.30 per share for a total value of $45,000, as compensation, for current services. As per the agreement, 90 days after the date of the agreement, the Company will be required to issue an additional 150,000 common shares valued at $0.45 per share for a total value of $67,500. The shares were issued July 22, 2015. The Company was under contract to issue 150,000 common shares valued at $0.30 per share for a total value of $45,000 to a consultant, as compensation, for current and future services to be provided from June 1, 2015 through June 1, 2016. These shares were issued on July 22, 2015. In May 2015, the Company entered into a stock subscription agreement with an investor for him to purchase up to $30,000 of common stock at a price of $0.30 per share. In June 2015, the Company received $10,529 for that Stock Subscription Payable. The Stock Subscription Payable is scheduled, by contract, to be relieved no later than July 30, 2015, by the issuance of 35,097 shares of common stock at a value of $0.30 per share. In May 2015, the Company entered into a stock subscription agreement with an investor for him to purchase up to $15,000 of common stock at a price of $0.30 per share. In June 2015, the Company received $10,000 for that Stock Subscription Payable. The Stock Subscription Payable is scheduled, by contract, to be relieved no later than August 20, 2015, by the issuance of 50,000 shares of common stock at a value of $0.30 per share. In June 2015, the Company entered into a stock subscription agreement with an investor for him to purchase up to $3,000 of common stock at a price of $0.300.30 per share. The Stock Subscription Payable is scheduled, by contract, to be relieved no later than October 20, 2015, by the issuance of 10,000 shares of common stock at a value of $0.30 per share. In August 2015, under a consulting agreement the Company issued 150,000 shares of restricted common stock valued at $0.45 per shares. In September 2015, the Company entered into a second agreement with the consultant and issued 150,000 shares of restricted common stock valued at $0.45 per share. The consultant, under the terms of the agreement, will receive an additional 150,000 shares of stock per year for services rendered. In August 2015, the Company issued 35,097 shares of its restricted common stock at a price of $0.30 per share in fulfillment of its obligations of a stock subscription agreement. In September 2015, the Company issued 15,111 shares of its restricted common stock at a price of $0.45 per share in fulfillment of its obligations of a stock subscription agreement. The Company has entered into subscription agreements to provide funding to support operating expenses. At September 30, 2015, there is $35,750 in subscriptions payable with stock prices of $0.30 to $0.45 per share, which obligation will be relieved by the issuance of 94,722 shares of restricted common stock.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2015
Notes
Commitments and Contingencies	NOTE 7 - COMMITMENTS AND CONTINGENCIES Operating Lease Obligations The Company leases office space for which it incurred lease payments, on a month to month basis, beginning in February of 2012 for $1,000 per month. The Company also had a one year lease on lab space beginning April 1, 2012 and ending March 31, 2013, with a monthly lease payment of $388. Pursuant to the lease agreement, at the end of one year, the term is month to month at the same rate of $388 per month.

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2015
Notes
Related Party Transactions	NOTE 8 - RELATED PARTY TRANSACTIONS Contributed Services During the nine months ended September 30, 2015 and 2014, the Company officers contributed services to the Company in the amount of $409 and $9,255 respectively. The Company officers received no compensation and have no expectation of compensation for these services, either now or in the future, and waive their rights to any such compensation. Compensation of Officers Its 2012 the Company agreed to compensate its Chief Executive Officer $3,600 per month. Beginning in January 2013 the Company agreed to compensate its CEO $3,550 per month. In February 2015, the Company began compensating the Vice President of Technology and the Vice President of Scientific Development $2,000 per month for services provided to the Company.

Loan Payable

Loan Payable	9 Months Ended
	Sep. 30, 2015
Notes
Loan Payable	NOTE 9 - LOAN PAYABLE The Company received, during the year ended December 31, 2013, proceeds from a loan in the amount of $91,600. The Lender agreed to loan the Company up to $10,000 per month effective September 2012, for up to one year. This loan was memorialized in writing on September 30, 2013. The loan is considered to be a demand note, with a maturity 30 days from the receipt of demand and the holder may not make demand for payment until six month from the date thereof. On September 30, 2015, the Company accrued additional interest on this note, at a rate of 8.0% in the amount of $7,785 for nine months. The total loan balance and accrued interest is $130,100 and $26,513 respectively. The note contains a conversion option. The conversion price is one share for each $0.01 of principal and accrued but unpaid interest of the note subject to a beneficial ownership limitation. That limitation prevents the holder from owning more than 4.9% of the number of shares of the common stock outstanding after conversion. If the holder's ownership has not previously been reduced to less than 4.9% of the number of shares outstanding, then the limitation shall be 9.9%. On September 4, 2013 the Company entered into an agreement with a shareholder wherein shareholder would provide financing to the Company for two months at $$25,000 per month. The note is due six months from the date it is presented and surrendered to the Company and bears an interest rate of 8% per annum. In September and October 2013, the Company received two $25,000 loans for a total of $50,000, and on October 28, 2013, the outstanding balance of $50,000 along with accrued interest of $500 was converted into common stock at a value of $0.30 per share. On November 14, 2012, the Company issued a $100,000 convertible promissory note to a consultant as compensation for services provided and to be provided during the period April, 1, 2012, through March 31, 2013. This note is due on demand, bears annual interest at 5.5%, and is convertible into shares of common stock at a conversion price to be agreed upon immediately prior to conversion. On September 27, 2013, the Company amended the note to include the conversion price which is one share for each $0.01 of principle and accrued but unpaid interest of the note. Of the original $100,000, $75,000 had been expensed as part of the professional/consulting fees on the statement of operations during the year ended December 31, 2012, and the remaining $25,000 was expensed ratably using the straight-line method over the last three months in the service period. On September 30, 2015, the Company has accrued additional interest on this note in the amount of $4,113 for the nine months ended September 30, 2015. As of September 30, 2015, the company accrued interest on this note in the total amount of $19,242. The Company has evaluated these convertible notes under the provisions of ASC Topic 815 and has concluded that neither of the convertible notes contains an embedded derivative requiring bifurcation from the host contract. Therefore, we have accounted for the conversion features of these instruments in accordance with ASC Topic 470. Accordingly, we have recognized the value of beneficial conversion features in these instruments as the difference between the conversion price and the fair value of the Company’s common stock on the date of the transaction. As a result the Company has recognized debt discounts resulting from these beneficial conversion features amounting to $50,000 and $65,050, respectively, for the November 14, 2012 and September 27, 2013 notes. The value of these discounts is to be accreted to the loans over the remaining contractual lives of the loans. Accretion recognized as additional interest expense during the periods ended December 31, 2014 and December 31, 2013 was $30,716 and $84,334, respectively. The ending value of the debt discount as of September 30, 2015, and December 31, 2014, was $0 and $0, respectively.

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2015
Notes
Subsequent Events	NOTE 10 - SUBSEQUENT EVENTS In October 2015 the Company entered into a stock subscription agreement with an investor for him to purchase up to $15,000 of common stock at a price of $0.45 per share. On October 19, 2015 the Company issued 33,333 common shares valued at $0.45 per share to relieve the Stock Subscription Payable in the amount of $15,000. On October 7, 2015 the Company issued 50,000 common shares valued at $0.30 per share to relieve the Stock Subscription Payable in the amount of $15,000. On October 28, 2015 The Company issued 150,000 shares of restricted common stock to a consultant in compliance with the terms of the consulting agreement entered into. The consultant is to receive, upon mutual agreement that the services have been adequately performed, an additional 150,000 shares of restricted common stock within 180 days. On October 28, 2015 the Company issued 15,556 common shares valued at $0.45 per share to relieve the Stock Subscription Payable in the amount of $7,000 entered into in October 2015.

Organization and Description 13

Organization and Description of Business (Policies)	9 Months Ended
	Sep. 30, 2015
Policies
Accounting Method	a. Accounting Method The Company’s financial statements are prepared in accordance with accounting principles generally accepted in the United States of America. In the opinion of management, all adjustments which are necessary for a fair statement of the results for interim periods have been included.
Revenue Recognition	b. Revenue Recognition The Company is currently developing its products. It is anticipated that revenue will be recognized on product sales once the product has been shipped to the customers, persuasive evidence of an agreement exists, the price is fixed or determinable, and collectability is reasonably assured.
Estimates	c. Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Cash and Cash Equivalents	d. Cash and Cash Equivalents The Company considers all deposit accounts and investment accounts with an original maturity of 90 days or less to be cash equivalents.
Fixed Assets	e. Fixed Assets Fixed assets are stated at cost. Expenditure for minor repairs, maintenance, and replacement parts which do not increase the useful lives of the assets are charged to expense as incurred. Expenditures, exceeding $500, for new assets or that increase the useful life of existing assets are capitalized. Depreciation is computed using the straight-line method. The lives over which the fixed assets are depreciated are five to seven years.
Earnings Per Share	f. Earnings per Share The computation of earnings per share of common stock is based on the weighted average number of shares outstanding during the period of the financial statement as follows: For the Nine Months ended September 30, 2015 For the Nine Months ended September 30, 2014 Net loss (numerator) $ (823,228) $ (658,836) Shares (denominator) 35,096,863 32,287,604 Net loss per share amount $ (0.02) $ (0.02) Diluted earnings per share is computed using the weighted average number of common shares plus dilutive common share equivalents outstanding during the period. During the year there were no outstanding common stock equivalents. Furthermore, due to the net loss for the year, common stock equivalents would not be included in the calculation of the net loss per common share, as their inclusion would be anti-dilutive.
Income Taxes	g. Income Taxes Deferred taxes are provided on an asset and liability approach whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax basis. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.
Equity Instruments Issued For Non-cash Items	h. Equity Instruments Issued for Non-Cash Items In accordance with ASC Topic 718, the Company records equity instruments issued for non-cash items at the grant-date fair value of the equity instruments issued.
Going Concern	NOTE 3 - GOING CONCERN The Company anticipates that the funds on hand as of September 30, 2015, will not be sufficient and funding through the sale of equity capital and short term related party and other shareholder loans in order to meet the planned expenditures for development, operations, and administrative cost over the next 12 months will be required. Planned expenditures are approximately $300,000 for the next twelve months. The Company is currently funded through November 30, 2015. The Company is in the process of arranging for additional necessary funding and currently retains consultants for that purpose. Management will adjust any salaries and expenditures based on the need for successful continuous operations. If plans to obtain further financing prove to be insufficient to fund operations, continued viability could be at risk. These factors raise substantial doubt about the Company's ability to continue as a going concern.

Organization and Description 14

Organization and Description of Business (Tables)	9 Months Ended
	Sep. 30, 2015
Tables/Schedules
Schedule of Earnings Per Share, Basic and Diluted	For the Nine Months ended September 30, 2015 For the Nine Months ended September 30, 2014 Net loss (numerator) $ (823,228) $ (658,836) Shares (denominator) 35,096,863 32,287,604 Net loss per share amount $ (0.02) $ (0.02)

Fixed Assets (Tables)

Fixed Assets (Tables)	9 Months Ended
	Sep. 30, 2015
Tables/Schedules
Property, Plant and Equipment	September 30, 2015 December 31, 2014 Equipment $ 49,373 $ 49,373 Accumulated depreciation (17,423) (11,995) Total Fixed Assets $ 31,950 $ 37,379

Organization and Description 16

Organization and Description of Business (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Details
Net loss	$ (307,378)	$ (242,944)	$ (823,228)	$ (658,836)
Weighted average common shares outstanding - basic and diluted	35,819,237	32,834,606	35,096,863	32,287,604
Basic and diluted loss per share	$ (0.01)	$ (0.01)	$ (0.02)	$ (0.02)
Planned expenditures			$ 300,000

Fixed Assets (Details)

Fixed Assets (Details) - USD ($)	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014
Details
Property, Plant and Equipment, Gross	$ 49,373		$ 49,373
Accumulated Depreciation	(17,423)		(11,995)
Property and equipment, net	31,950	$ 37,379	$ 37,379
Depreciation	$ 5,429	$ 5,196

Preferred and Common Stock (Det

Preferred and Common Stock (Details) - USD ($)	1 Months Ended						9 Months Ended
	Oct. 31, 2015	Sep. 30, 2015	Aug. 31, 2015	Jun. 30, 2015	May. 31, 2015	Apr. 30, 2015	Sep. 30, 2015	Sep. 15, 2015	Jul. 22, 2015	Jun. 15, 2015	Apr. 15, 2015	Apr. 02, 2015	Dec. 31, 2014	Sep. 30, 2014	Oct. 19, 2011
Details
Preferred stock authorized		10,000,000					10,000,000						10,000,000		10,000,000
Preferred stock par value		$ 0.001					$ 0.001						$ 0.001		$ 0.001
Stock Issued During Period, Value, New Issues	$ 15,000			$ 3,000	$ 30,000	$ 30,000
Sale of Stock, Price Per Share	$ 0.45	$ 0.30	$ 0.45		$ 0.45		$ 0.30	$ 0.45		$ 0.30
Stock Issued During Period, Shares, Other					150,000	100,000
share based compensation shares		150,000					150,000		150,000		800,000	150,000
share based compensation value		$ 45,000					$ 45,000		$ 45,000		$ 240,000	$ 45,000
Stock Issued During Period, Value, Other					$ 67,500		$ 10,529
Second May Stock Subscription							35,097
Third May Stock Subscription Amount					$ 15,000
Third May Stock Subscription							$ 10,000
Third May Stock Subscription Shares							50,000
June Stock Subscription Shares							10,000
Stock Issued During Period, Shares, Issued for Services	150,000		150,000
Stock Issued During Period Shares Second Issuance For Services		150,000
Stock Issued During Period, Shares, New Issues	33,333	15,111	35,097
Stock subscription payable		$ 35,750					$ 35,750							$ 0
Shares Issued During Period Shares Fourth Issuance							94,722

Commitments and Contingencies (

Commitments and Contingencies (Details)	9 Months Ended
	Sep. 30, 2015USD ($)
Details
monthly office lease payment	$ 1,000
monthly lab lease payment	$ 388

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)	6 Months Ended	9 Months Ended		12 Months Ended
	Sep. 30, 2015	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2013	Dec. 31, 2012
Details
Services contributed by officers		$ 409	$ 9,255
Officers' Compensation	$ 2,000			$ 3,550	$ 3,600

Loan Payable (Details)

Loan Payable (Details) - USD ($)	9 Months Ended		12 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2014
Details
Additional Loan Proceeds	$ 91,600
Accounts Payable, Interest-bearing, Interest Rate	8.00%
additional loan accrued interest	$ 7,785
Convertible Notes Payable	130,100
Represents the monetary amount of ConvertibleNotePayableAccruedInterest, during the indicated time period.	$ 26,513
Debt Instrument, Convertible, Terms of Conversion Feature	The conversion price is one share for each $0.01 of principal and accrued but unpaid interest of the note subject to a beneficial ownership limitation. That limitation prevents the holder from owning more than 4.9% of the number of shares of the common stock outstanding after conversion. If the holder's ownership has not previously been reduced to less than 4.9% of the number of shares outstanding, then the limitation shall be 9.9%.
Shareholder Loan Amount Per Month	$ 25,000
Related Party Transaction, Amounts of Transaction	50,000
Debt Conversion, Converted Instrument, Amount	50,000
Debt Conversion Accrued Interest	$ 500
Debt Instrument, Convertible, Conversion Price	$ 0.30
November convertible promissory note	$ 100,000
Debt Conversion, Original Debt, Interest Rate of Debt	5.50%
Price per share	$ 0.01
Decrease in prepaid expenses	$ 133,852	$ 0		$ 75,000
Consulting fee balance expensed	25,000
Additional Convertible Promissory Note Accrued Interest	4,113
Second Convertible Note Payable Accrued Interest	19,242
Debt Instrument, Convertible, Beneficial Conversion Feature			$ 65,050	$ 50,000
additional interest expense			$ 84,334		$ 30,716
The ending value of the debt discount	$ 0				$ 0

Subsequent Events (Details)

Subsequent Events (Details) - USD ($)	1 Months Ended
	Oct. 31, 2015	Sep. 30, 2015	Aug. 31, 2015	Jun. 30, 2015	May. 31, 2015	Apr. 30, 2015	Sep. 15, 2015	Jun. 15, 2015
Details
Stock Issued During Period, Value, New Issues	$ 15,000			$ 3,000	$ 30,000	$ 30,000
Sale of Stock, Price Per Share	$ 0.45	$ 0.30	$ 0.45		$ 0.45		$ 0.45	$ 0.30
Stock Issued During Period, Shares, New Issues	33,333	15,111	35,097
Stock Issued During Period Shares Second Issuance	50,000
Stock Issued During Period Value Second Issuance	$ 15,000
Stock Issued During Period, Shares, Issued for Services	150,000		150,000
Stock Issued During Period Shares Third Issuance	15,556
Stock Issued During Period Value Third Issuance	$ 7,000